SHARON PRIOR: Open Payments
NPI 1073183935 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,822 in 140 payments from 17 companies in 2025. Trend: 2023 $4,485 · 2024 $3,807 · 2025 $2,822
Food & beverage: $2,822
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $521 |
| Otsuka America Pharmaceutical, Inc. | 23 | $358 |
| Vanda Pharmaceuticals Inc. | 8 | $314 |
| Lundbeck LLC | 13 | $219 |
| Collegium Pharmaceutical, Inc. | 12 | $213 |
| Teva Pharmaceuticals USA, Inc. | 9 | $209 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $164 |
| ABBVIE INC. | 9 | $152 |
| Neurocrine BioSciences, Inc. | 6 | $145 |
| Alkermes, Inc. | 6 | $129 |
Products named: REXULTI, CAPLYTA, FANAPT, Jornay PM, AUSTEDO XR, TRINTELLIX, VRAYLAR, INGREZZA.
Industry payments across NY — which companies pay providers there.
